Educational in-silico preprint describing the computational logic of an IL-4Rα-focused asthma blocker prototype for type-2 inflammatory pathway hypothesis generation. The work documents FASTA-style input, candidate representation, checkpoint scoring, and cautious interpretation only. No clinical, therapeutic, diagnostic, wet-lab, delivery, dosing, expression, or regulatory claim is made.
Rami Alkhaleeli (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: